In 1997, I began as an academic physician at UC Davis. I developed a productive, independent laboratory-based research program, and as the Director of Hematologic Malignancies Program created one of the most productive clinical trials programs at the UC Davis Comprehensive Cancer Center. I currently am the deLeuze Endowed Professor for the non-toxic cure for lymphoma, Director of Bone Marrow and Stem Cell Transplantation and the interim Division Chief of Malignant Hematology Cellular Therapy and Transplantation.
My research has focused on immune-mediated therapeutics to reduce toxicity and enhance efficacy, including development of antibody drug conjugates, antibody-targeted liposomes, development of alternative natural products, and bi- and tri-specific antibodies.
This work resulted in some 38 publications, 3 VA Merit and 12 intramural awards, and 3 patents (1 pending), which has facilitated ongoing funding of my lab and established me as an expert in targeted immuno-therapeutics.